Also see the KNAW website.jpg?h=200&w=200&hash=12FCA9021ECDAFB65BCEC803F4199C63)
The prize will be awarded at the Dutch Annual Virology Symposium (DAVS) on March 21, 2025
Development of therapies against rabies
Carmen Embregts (1989) is a researcher at the Viroscience department of the Erasmus MC in Rotterdam. Her research focuses on how, where and when the rabies virus suppresses the immune response, with special attention to the earliest stages of infection and the influence of this on cells of the innate immune system. The jury is impressed by the strong, independent line of research in Embregts' work, and recognizes in her work a unique expertise in the field of the rabies virus and working in laboratories specifically for this purpose.
Embregts wants to use the prize for a visit to the International Centre for Diarrhoeal Disease Research in Bangladesh.
Carmen Embregts:
'Thanks to the Beijerinck Prize, I can set up a line of research in an area where rabies is common, and make an important translation from experimental (lab) infections to natural infections. In the planned study I will collect unique patient materials to closely examine the immune response to rabies virus; the insights gained will contribute to the development of therapies that are currently not available.'
